LEPU BIO-B News

LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 6 13:06

LEPU BIO-B: VOLUNTARY ANNOUNCEMENT UPDATE ON THE LICENSE AGREEMENT WITH ASTRAZENECA FOR CMG901

Apr 15 08:07

LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 3 14:55

LEPU BIO-B: VOLUNTARY ANNOUNCEMENT FAST TRACK DESIGNATION GRANTED BY THE FDA TO MRG004A FOR THE TREATMENT OF PANCREATIC CANCER

Mar 11 08:03

LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 5 14:54

LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 5 10:31

LEPU BIO-B: ARTICLES OF ASSOCIATION

Jan 31 21:10

LEPU BIO-B: List of Directors and their Roles and Functions

Jan 31 21:05

LEPU BIO-B: PROXY FORM FOR USE AT THE 2024 SECOND EXTRAORDINARY GENERAL MEETING

Jan 16 21:55

LEPU BIO-B: (1) PROPOSED RE-ELECTION OF THE BOARD OF DIRECTORS; (2) RETIREMENT OF CO-CHIEF EXECUTIVE OFFICER AND DIRECTORS; (3) PROPOSED RE-ELECTION OF SUPERVISORS; AND (4) PROPOSED AMENDMENTS OF THE ARTICLES OF ASSOCIATION

Jan 16 21:48

LEPU BIO-B: PROXY FORM FOR USE AT THE 2024 FIRST EXTRAORDINARY GENERAL MEETING

Jan 16 19:59

LEPU BIO-B: Notification Letter with Request Form to Non-Registered Shareholders

Jan 16 18:58

LEPU BIO-B: Notification Letter with Request Form to Registered Shareholders

Jan 16 18:52

LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 4 10:54

LEPU BIO-B: VOLUNTARY ANNOUNCEMENT COMPLETION OF PATIENT ENROLLMENT OF PIVOTAL PHASE IIb CLINICAL TRIAL FOR MRG003 FOR THE TREATMENT OF R/M NPC

Dec 29, 2023 06:12

LEPU BIO-B: VOLUNTARY ANNOUNCEMENT ORPHAN-DRUG DESIGNATION GRANTED BY THE FDA TO MRG004A FOR THE TREATMENT OF PANCREATIC CANCER

Dec 14, 2023 17:24

LEPU BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 4, 2023 11:02

LEPU BIO-B: VOLUNTARY ANNOUNCEMENT FAST TRACK DESIGNATION GRANTED BY THE FDA TO MRG003 FOR THE TREATMENT OF R/M NPC

Dec 4, 2023 08:03

LEPU BIO-B: PROXY FORM FOR USE AT THE 2023 SECOND EXTRAORDINARY GENERAL MEETING

Nov 14, 2023 07:37

LEPU BIO-B: (1) RESOLUTIONS RELATING TO THE PROPOSED ADDITIONAL METHOD FOR THE PUBLIC TRADING ON THE PRC DOMESTIC CAPITAL MARKET; (2) PROPOSED AMENDMENTS TO THE ARTICLES ANCILLARY TO THE PROPOSED QUOTATION; AND (3) NOTICE OF THE 2023 SECOND EXTRAORDINARY G

Nov 14, 2023 07:13